Alerts will be sent to your verified email
Verify EmailAMBALALSA
Ambalal Sarabhai Ent
|
Vaidya Sane Ayur Lab
|
Balaxi Pharma.
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
0.01 % | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
19.11 % | 8.39 % | 29.33 % |
5yr average Equity Multiplier
|
2.07 | 1.34 | 1.4 |
5yr Average Asset Turnover Ratio
|
0.75 | 1.57 | 1.5 |
5yr Avg Net Profit Margin
|
10.89 % | 3.83 % | 11.83 % |
Price to Book
|
1.81 | 0.0 | 1.13 |
P/E
|
51.24 | 36.08 | 10.43 |
5yr Avg Cash Conversion Cycle
|
-37.53 Days | -76.76 Days | 133.11 Days |
Inventory Days
|
33.51 Days | 11.33 Days | 87.41 Days |
Days Receivable
|
63.69 Days | 24.16 Days | 103.86 Days |
Days Payable
|
147.98 Days | 116.68 Days | 63.18 Days |
5yr Average Interest Coverage Ratio
|
9.88 | 6.88 | 57.05 |
5yr Avg ROCE
|
24.01 % | 12.91 % | 40.34 % |
5yr Avg Operating Profit Margin
|
5.29 % | 7.94 % | 18.05 % |
5 yr average Debt to Equity
|
0.32 | 0.02 | 0.05 |
5yr CAGR Net Profit
|
-30.01 % | -10.61 % | -5.76 % |
5yr Average Return on Assets
|
8.69 % | 6.19 % | 20.09 % |
Shareholdings
|
|||
Promoter Holding
|
31.35 % | 66.34 % | 65.99 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.59 % | 0.0 | -6.87 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Ambalal Sarabhai Ent
|
Vaidya Sane Ayur Lab
|
Balaxi Pharma.
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Capex
|
Capex
|
Capex
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|